The osmotic demyelination syndrome (ODS) is a non-primary inflammatory disorder of the central nervous system myelin that is often associated with a precipitous rise of serum sodium concentration. To investigate the physiopathology of ODS in vivo, we generated a novel murine model based on the abrupt correction of chronic hyponatremia. Accordingly, ODS mice developed impairments in brainstem auditory evoked potentials and in grip strength. At 24 hr post-correction, oligodendrocyte markers (APC and Cx47) were downregulated, prior to any detectable demyelination.
severe hyponatremia was experimentally confirmed using a rat model (Kleinschmidt-DeMasters & Norenberg, 1981) and by systematic blood analysis of symptomatic ODS patients. Nowadays, plasma sodium level is tightly monitored in patients presenting severe hyponatremia upon hospital admission and clinical guidelines have been issued regarding the management of hyponatremia or its correction to prevent potential, ensuing brain damages (Spasovski et al., 2014) . The initial mechanism triggering demyelination remains unclear, although it was suggested that blood-borne myelinotoxic factors or inability of glial cells to restore their stocks of organic osmolytes (lost during chronic hyponatremia) at the time of correction might be responsible for osmotic cell damages (Lien, 1995; Lien, Shapiro, & Chan, 1991) . Animal models (i.e., rat and dog) have been generated in order to unravel the selective loss of myelin or oligodendrocytes (Illowsky & Laureno, 1987; Laureno, 1983; Verbalis & Drutarosky, 1988) . For instance, the rapid correction of chronic hyponatremia in rats recapitulates human ODS histopathology, including myelin and oligodendrocyte loss with neurons and axons sparing in specific brain regions such as cortical regions, hippocampus and basal ganglia (Gankam Kengne et al., 2011; Kleinschmidt-DeMasters & Norenberg, 1981) . In a rat model of ODS, it was previously shown that astrocytes underwent apoptosis before any evidence of myelin or oligodendrocyte loss (Gankam Kengne et al., 2011) . Abnormal loss of astrocytic aquaporins has also been demonstrated in human CPM autopsy cases, stressing the involvement of non-oligodendroglial cells in the development of ODS (Popescu et al., 2013) . During the course of ODS, microglial cells acquire an activated phenotype and colocalized with the demyelinating lesions, as observed in human cases (Adams et al., 1959; DeLuca, Nagy, Esiri, & Davey, 2002; Popescu et al., 2013) and in the rat model (Gankam-Kengne, Soupart, Pochet, Brion, & Decaux, 2010; Takefuji et al., 2007) . The detection of activated microglial cells in ODS lesions has been linked to the secretion of pro-inflammatory cytokines and the clearance of myelin debris or damaged nervous cells (Iwama et al., 2011) .
Rats have traditionally been the preferred species used through the ODS research community. Nevertheless, the development of genetically modified animals, which are primarily mouse models, have paved the way for the manipulation of genes or cells possibly relevant to the pathophysiology of ODS. So far, three studies sought to create murine models of ODS (Sugimura et al., 2002; Thurston, Hauhart, & Nelson, 1987) . Although the authors noticed neurological symptoms related to ODS, the publications failed to depict the full histopathological outcomes (i.e., myelin loss), or did not temporally investigate the cellular changes that could be observed after correction of hyponatremia.
The present study describes a novel mouse ODS model which reproduces pathologic changes similar to human ODS in specific CNS regions. The CNS changes studied mainly encompass functional and histopathological alterations in the thalamus region and include analysis of molecular and cellular markers along with some preliminary ultrastructural data. Altogether, the study attempts to further clarify the timely progress of the damages pertaining to the oligodendrocytes, astrocytes and microgliocytes as well as of myelin and blood-brain barrier (BBB) integrity.
| M A TER I A LS A N D M ETH OD S

| Animals
The experimental protocol was conducted in compliance with the European Communities Council Directives for Animal Experiment (2010/ 63/EU, 86/609/EEC and 87-848/EEC) and was approved by the Animal Ethics Committee of University of Namur (ethic project n814-210).
Male C57bl/6J mice, aged from 3 to 4 months were included in the study. Unless otherwise specified, any procedure involving anesthesia was performed using i.p. injection of a cocktail of Ketamine 100 mg/kg and Xylazine 5 mg/kg.
| ODS protocol
ODS induction was based on the correction of a chronic dilutional hyponatremia, according to an adapted protocol (Verbalis & Drutarosky, 1988) . Briefly, an osmotic minipump (Model 1004, Alzet, Cupertino, CA) was filled with desmopressin acetate (0.002 mg/ml; Minirin, Ferring, Saint-Prex, Switzerland) and inserted subcutaneously under anesthesia into the back of animals at day 0. Standard pellets and water were switched to a low-sodium liquid diet (AIN76A, MP Biomedicals, Santa Ana, CA), given ad libitum for the whole duration of hyponatremia. At day 4, hyponatremia level was measured and serum sodium was increased close to normonatremia using a single intraperitoneal injection of NaCl 1M (1.5 ml/100 g body weight). Minipumps were left into animals until the end of experiments. Animals had access to standard pellets and water ad libitum at day 5, after natremia measurement. All animals were daily monitored according to a previously described neurological scale (Sugimura et al., 2005) .
| Natremia measurements
After topical application of lidocaine, blood samples (25 ml) were collected by tail puncture. Natremia was measured on whole-blood sample on Spotchem EL SE-1520 electrolyte analyzer (Arkray, Kyoto, Japan) using ion-selective electrodes and potentiometry. Some samples were compared with standard flame spectrophotometry (Supporting Information, Figure S1 ).
| Grip strength
Limb muscle strength was determined using a Grip Strength Meter (Bioseb, Vitrolles, France). Grip strength testing was performed by allowing the animals to grasp a grid attached to the force gauge using all four limbs. This was followed by pulling the animal away from the gauge until the limbs released the grid, this provides a value for the force of maximal grip strength. The force measurements were recorded in three trials, and the averages were used in analyses.
| Brainstem auditory evoked potentials
Mice were anesthetized using isoflurane (1.5%) in oxygen inhalation.
They were placed on a heating pad and their body temperature was maintained throughout the experiment. Adapted insets were connected to earphones (Caldwell 10 Ohms) by 10 cm silicone tubing and were inserted into both ear canals. The left ear was stimulated using clicks of 0.1 ms duration and 90 dB normal hearing level intensity delivered at 11.1/s, while the right ear received a continuous 60 dB masking noise from the stimulator (Caldwell Sierra II XP). Brainstem auditory evoked potentials (BAEPs) were recorded using subdermal needle electrodes: the electrode connected to the non-inverting input of the preamplifier was positioned at the vertex of the skull and the one connected to the inverting input was inserted at the level of the left mastoid process; the ground electrode was inserted at the neck level. The amplitude and latency of peaks I-V were measured using the Caldwell Wedge 3.3.3.
software.
| Histology and immunohistochemistry
Under anesthesia, mice were exsanguinated and transcardially perfused with NaCl 0.9% followed by phosphate-buffered 4% paraformaldehyde (PFA). Brains were removed, divided into two hemispheres and postfixed overnight in fixative. Brains were then dehydrated, paraffinembedded and processed into 6-mm sections using a microtome. Paraffin sections were dewaxed, rehydrated and stained with Eriochrome Cyanine R/Cresyl Violet or Perls Prussian blue according to previously published protocols (Nicaise et al., 2009; Nicaise et al., 2012) . Sections were dehydrated in ethanol 95% and mounted in DPX (Merck Millipore, Darmstadt, Germany).
For immunohistochemistry, sections were dewaxed, rehydrated and heat-induced antigen retrieval was performed in citrate buffer pH 6 at 1008C for 10 min. Endogenous peroxidase was quenched using 3% H 2 O 2 in methanol for 10 min. Non-specific binding was blocked using 5% horse or goat serum diluted in Tris-buffered saline (TBS) for 15 min. Primary antibodies (Table 1) were diluted into TBS and sections were incubated overnight at 48C. Next, sections were incubated with a biotinylated secondary antibody (1:100, Vectastain, Vector Laboratories, Burlingame, CA) for 1 hr at room temperature. Sections were then incubated with a solution of peroxidase-bound streptavidin (1:100; Vectastain) for 45 min. Revelation was done using diaminobenzidine substrate (Dako, Glostrup, Denmark 
| RNA isolation and qRT-PCR
Under anesthesia, mice were exsanguinated and transcardially perfused with cold NaCl 0.9%. Brains were harvested, thalamus were microdissected, snap-frozen in liquid nitrogen and then stored at 2808C.
Thawed samples were homogenized in Trizol reagent (Life 
| Western blot
Proteins were extracted from micro-dissected thalamus samples using a lysis buffer containing Tris-HCl pH 6.8 0.5 M, glycerol, sodium dodecyl sulfate 10% and dithiothreitol 200 mM. Samples were boiled at 1008C for 5 min and then centrifuged at 48C at 10,000 rpm for 3 min. Protein concentration was measured using the Pierce protein assay kit (Thermo Scientific, Bleiswijk, Netherlands). Ten mg of 
| BBB permeability
Evans Blue was intraperitoneally injected 1 hr before sacrifice. Animals were exsanguinated and transcardially perfused with NaCl 0.9%, until blood was fully withdrawn. Prosencephalons were isolated, weighted before snap-freezing into liquid nitrogen, and then stored at 2808C until analysis. Samples were thawed, digested in 250 ml formamide for 3 days at 658C. Next, samples were centrifuged at 13,000 rpm for 10 min at 48C and supernatants analyzed with spectrophotometry at 620 nm. Dye concentration in the sample was interpolated from a standard curve and normalized with the wet weight of the tissue. ). Hyperkalemia was still measured in corrected mice at 24 hr and lasted over time (7.4 6 1.3 mEq/L, p < .001).
| Statistical analysis
34% of corrected mice were found dead in their cages the day after correction, without having gotten the opportunity to measure their natremia. The mean 24-hr DSNa 1 for mice included in the study was 33 6 7 mEq/L (Table 3) 
| ODS mice showed impairments of grip strength and auditory evoked potentials
Compared with normonatremic and uncorrected hyponatremic mice, corrected ODS mice showed lower muscular strength at 24 hr after the correction. Surprisingly, ODS mice at 48 hr after the correction presented no statistically relevant differences ( Figure 1b) . As ODS has previously been described to affect white matter tracts along the auditory pathway in human cases, we measured BAEPs before and after correction of hyponatremia. ODS mice showed significant lower amplitudes for waves III and V at 24 hr after the correction (Figure 1d ), together with higher latencies (Figure 1e ). Peak I mostly results from the afferent action potential volley in the auditory nerve; peaks III-V are generated by brainstem structures caudal to the caudal colliculi. No differences were observed for amplitude or latency for wave I (Figure 1c,d ).
3.3 | Demyelinating lesions were observed in ODS mice 48 hr after the correction of hyponatremia Surviving ODS mice showed partial recovery from 72 hr to latter time point (a) (**p < .01; ***p < .001, Kruskal-Wallis test, D0 n 5 30, D1 n 5 30, D2 n 5 30, D3 n 5 30, D4 n 5 30, D5 n 5 30, D6 n 5 30, D7 n 5 14, D8 n 5 6). Normonatremic mice (NN) and chronic uncorrected hyponatremic mice (HN) showed no deficit in muscle strength. Grip strength was significantly impaired at 24 hr postcorrection in ODS mice (b) (***p < .001 vs. NN group, Kruskal-Wallis test, NN n 5 13, HN n 5 13, 24 hr n 5 13, 48 hr n 5 5). For brainstem auditory evoked potentials (BAEPs), the amplitudes of waves I, III, and V were slightly decreased in ODS mice after correction (c). The latency of waves III and V (analysis between peaks I and III and between peaks I and V) was significantly delayed at 24 hr after correction in ODS compared with NN mice (d) (*p < .05, **p < .01, Kruskal-Wallis test, NN n 5 12, HN n 5 12, 24 hr n 5 12, 48 hr n 5 4). All data are expressed as mean 6 SEM chronic hyponatremia, APC immunoreactivity dropped drastically (Figure 3a) . A significant reduction of APC 1 labeled cells was identified at 24 hr after the correction, which is also 24 hr before any significant myelin loss (Figure 3b ). Loss of p25a 1 oligodendrocytes in thalamus corroborated loss of APC immunoreactivity (data not shown). Furthermore, a double immunolabeling for myelin and oligodendrocytes (Figure 3c) at the same time-point confirmed oligodendrocytopathy prior to myelin loss. At 48 hr post-correction, the injury to oligodendrocytes was spatially correlated to myelin loss in the thalamus and each other susceptible brain regions surveyed. In contrast, astrocytes are being functionally coupled to oligodendrocytes in the panglial syncytium.
Loss of ALDH1L1 immunoreactivity, a specific astrocyte marker, was detected in same susceptible brain regions within 24 hr after the osmotic injury (Figure 3d ,f). The regional damages coincided spatially and temporally with the regions that are impacted by demyelination, as attested by double immunolabeling MBP/ALDH1L1 and SMI94/ ALDH1L1 (Figure 3d-f) . Loss of other astrocyte markers such as AQP4
and S100b corroborated temporally and spatially ALDH1L1 immunohistochemical results (data not shown). Morphology of ALDH1L1 astrocytes was followed up from 6 hr post-correction to late time points and revealed early clasmatodendrosis (Supporting Information, Figure S3 ).
| Dysregulation of astrocytes/oligodendrocytes (A/O) gap junctions
In ODS brains, less Cx47 1 cells were counted in the thalamus than in hyponatremic brains (Figure 4a,b) . Although Cx47 protein expression showed no obvious difference between groups (Figure 4c ), expression of Cx47 mRNA showed a trend to decrease at 24 hr after the correction (Figure 4d ). In brain slices, Cx43 immunoreactivity decreased at 24
and 48 hr after the correction of hyponatremia (Figure 4e,f) . This latter change was correlated with a downregulation of Cx43 protein ( Figure   4g ) and gene expression (Figure 4h ).
| Osmotic injury leads glial cells toward necroptosis in ODS lesions
At the ultrastructural level, the thalamus of ODS mice at 12 hr postcorrection demonstrated that most oligodendrocytes were more 
| Expression changes of myelinotoxic and promyelinogenic factors
We performed qRT-PCR on several genes involved into cellular death 
| BBB disruption was observed 48 hr after the correction of hyponatremia
IgG immunoreactivity was not detected in the brain parenchyma from were stained with Perls' method but they never revealed the presence of hemosiderin deposits after careful inspection of all the sections prepared (data not shown).
| Early microglial activation in ODS mice
In normonatremic and hyponatremic mice, quiescent Iba1 1 microglial cells were observed throughout the brain. They presented a ramified morphology typical of a resting state, namely type A (Figure 8a Central nucleus of inferior colliculus 14
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BOUCHAT ET AL. protein Western blots analyses revealed no difference between groups (c). Relative analysis of Cx47 mRNA was not significantly changed despite a trend toward diminution at 24 hr after the correction (d). Cx43-immunoreactivity decreased in thalamic nuclei after the correction (e). The quantification of Cx43 immunoreactivity showed a significant reduction at 48 hr after the correction, while a non-statistically diminution was already observed at 24 hr after the correction (f). Cx43 protein Western blot analyses also showed a sharp decrease after the correction (g) and the mRNA transcripts confirmed the downregulation of Cx43 expression (h) (*p < .05 compared with NN, ##p < .01 compared with HN, Kruskal-Wallis test, NN n 5 4, HN n 5 4, 24 hr n 5 6, 48 hr n 5 3). Results are expressed as mean 1 SEM in (b) and (f). mRNA results in (d) and (h) are expressed as RQ 6 SD. Scale bars 5 500 mm in a and 50 mm in e FIG URE 5 Necroptosis-dependent glial cell injuries in ODS lesions. 12 hr post correction, electron microscopy revealed chromatin hypercondensation and nucleolar changes in astrocytes and oligodendrocytes. At this time-point, myelin sheaths are not yet disrupted in ODS brains but glial cells showed autophagocytosis (white arrows). However, 48 hr after the correction, oligodendrocytes demonstrated stronger nuclear degradation than astrocytes (a). Cleaved caspase 3 was not detected in thalamic ODS samples (b) suggesting that apoptosis is not implicated in oligodendrocyte or astrocyte death. However, p-MLKL, a downstream effector of the necroptosis pathway demonstrated a strong immunoreactivity in and around lesioned areas (c, black arrows). pMLKL immunoreactivity appeared localized in the nucleus and on the neurolemma of many thalamic glial cells of ODS mice (inset). Scale bars 5 1 mm in c (top) and 500 mm in c (bottom) [Color figure can be viewed at wileyonlinelibrary.com]
FIG URE 6 Gene expression of myelinotoxic (TNFRSF6, FasL, TNFa, and IL-1b) and promyelinogenic (MBP, PLP1, CNP1, LIF, GDNF, and BDNF) factors. No differences were observed between normonatremic mice (NN) and hyponatremic mice (HN) for any of the genes analyzed. TNFRSF6 and FasL mRNA expressions were significantly increased after the correction compared with NN (a and b). An increasing trend of TNFa was observed (c) whereas a significant increase for IL-1b mRNA expression occurred after the correction compared with NN (d) . No difference between experimental groups for MBP (e), GDNF (i), and BDNF (j) were observed. PLP1 mRNA expression was statistically downregulated at 48 hr after the correction compared with NN (f). CNP1 mRNA levels were significantly downregulated at 24 hr after the correction compared with NN (g). LIF mRNA was significantly upregulated at 48 hr after the correction compared with NN (h) (*p < .05, **p < .01, ***p < .001, Kruskal-Wallis test, NN n 5 5, HN n 5 5, 24 hr n 5 9, 48 hr n 5 5). Results are expressed as RQ 1 SD mice. These values are close to those described in previous studies conducted in rats (Soupart, Stenuit, Perier, & Decaux, 1991) . Noteworthy, hemolysis was often observed after tail blood sampling, which could explain unexpected higher levels of K
1
. In this murine model, 34% of the mice died within the first day post-correction, whereas all the surviving mice invariably developed neurological manifestations of ODS, including sensory-motor deficits. In correlation with the functional impairments, myelin disorganization and loss were noted in related-brain areas, such as the pons, thalamic nuclei, inferior colliculus and cortical regions, consistent with human ODS lesion topography (Martin, 2004) . In this mice study, no lesions were detected in the hippocampus, cerebellum or putamen although these regions are impacted in human ODS. This discrepancy can be explained by species-specific cellular response to the correction of hyponatremia or alternatively by the differential content of susceptible brain regions. For instance, in ODS rat model, demyelinating lesions were rarely identified in the pons, although they are found in human patients and in the mouse model. This observation could be explained by comparable cyto-and myelo-architectures of murine and human pons, composed of an admixture of grey and white matters (Lindquist et al., 2016 ).
In our ODS mice model, the significant nuclear damages (chromatin condensation, loss of nucleolus and nuclear membrane disappearance) along with other deteriorating injuries found in most oligodendrocytes and some of the astrocytes of the susceptible brain regions, prior to demyelination corroborate the morphological losses of glial cell markers. These pathological events at cellular level prefigured myelin deterioration at 48 hr post-correction but also some aspects of glial cell death. Evidences of oligodendrocytic apoptosis were observed in human ODS samples (DeLuca et al., 2002) and in ODS rats (Gankam Kengne et al., 2011; Rojiani, Cho, Sharer, & Prineas, 1994) . Moreover, in the rat model, astrocytes undergo apoptosis before oligodendrocyte or myelin loss (Gankam-Kengne, Couturier, Soupart, Brion, & Decaux, 2017; Gankam Kengne et al., 2011) . We failed to replicate these findings in ODS mice as TUNEL assay, immunohistochemistry against cleaved caspase 3 and gamma H2AX; furthermore, anti-cleaved caspase 3 western blots were negative in lesioned brain areas. Given the upregulation of Fas (TNFRSF6) and FasL expression, it is hypothesized that an alternative mechanism can be responsible for the glial cell (Yoon, Bogdanov, Kovalenko, & Wallach, 2016) .
It is well established that oligodendrocytes and astrocytes act together to support myelin maintenance (Domingues, Portugal, Socodato, & Relvas, 2016; Tress et al., 2012) and disruption of myelin sheaths (Li, Giaume, & Xiao, 2014; Lutz et al., 2009; Odermatt et al., 2003) . In the thalamus of ODS mice, Cx43 and (Woodruff & Franklin, 1999) or in experimental autoimmune encephalitis models (Mei et al., 2016) .
Although ODS is not a primary inflammatory demyelinating disorder, the osmotic insult triggers a release of mediators of inflammation that are able to exacerbate the glial cell damages (Iwama et al., 2011 (Choi, Lee, Lim, Satoh, & Kim, 2014; Didier et al., 2003) , compromise oligodendrocyte survival (Su et al., 2011) or BBB impermeability (Argaw et al., 2006; Didier et al., 2003 This modification means that either these cells are able to sense the osmotic changes itself or they can respond to some damage-associated molecular patterns released from injured glial cells. Unlike the brains of rats and humans in which microglial activation is usually described in late ODS lesions (Adams et al., 1959; DeLuca et al., 2002; Popescu et al., 2013) , morphological changes in murine microglia were noted as early as 12 hr post-correction. So far, the trigger for the microglial activation is not known. Their early activation, associated with the release of inflammatory mediators suggests an active role in glial cell or myelin damages. As previously shown, administration of minocycline, an inhibitor of microglial activation, decreased brain demyelination in the rat model of ODS (Gankam-Kengne et al., 2010; Suzuki et al., 2010; Takagi et al., 2014) . In a more subtle way, it has been proposed that microglia could play a detrimental role in the early phase of ODS fostering brain inflammation but could turn into a protective phenotype during later phases by secreting trophic factors (Iwama et al., 2011) .
As previously demonstrated in rats undergoing correction of a chronic hyponatremia, the re-integration of organic osmolytes within different brain regions occurs at differential rates and the severity of demyelinating lesions inversely correlates with the local efficiency in replenishing osmolytes (Lien, 1995; Lien et al., 1991) . Accordingly, the regional susceptibility to osmotic insult might be related to differential abilities for single glial cells to quickly (re-)accumulate organic osmolytes and/or to glial cell heterogeneity among the brain regions. For instance, astrocytes from hippocampus, cerebellum or retina all exhibit different regulatory volume responses (Hirrlinger, Wurm, Hirrlinger, Bringmann, & Reichenbach, 2008) . Differences at the level of ion channels, transporters and receptors are increasingly reported among astroglial cells (Chatton, Magistretti, & Barros, 2016) . Brain astrocytes differ in their profile of gap junction expression, with CNS regions expressing specific subtypes of connexins (Griemsmann et al., 2015) . Astrocytes and oligodendrocytes gap junctions allow the passive diffusion of ions (Na supporting an ionic and metabolic sharing throughout the glial syncytium. Depending on the degree of coupling, differential abilities of controlling and distributing metabolic load might also explain the regionspecific vulnerability to anisosmotic conditions. Consistent with previous results obtained in the rat ODS model, the correction of hyponatremia affected astrocyte viability during the early phase of ODS in mice (Gankam-Kengne et al., 2017; Gankam Kengne et al., 2011) . Morphological analysis in lesioned thalamus revealed clasmatodendrosis starting at 6 hr after the correction, reflecting astrocytic irreversible injury (Hulse, Winterfield, Kunkler, & Kraig, 2001 ). The active involvement of astrocytes into brain energy metabolism and ion homeostasis leads us to suspect a pivotal role of astrocytes during ODS (Chatton et al., 2016; Rose & Verkhratsky, 2016) . Recently, one of us showed that astrocytes, but not oligodendrocytes, underwent severe defects in proteostasis, making of these cells a preferred target during the osmotic stress (Gankam-Kengne et al., 2017) . If true, oligodendrocytes might be considered as collateral damages indirectly affected by regional astrocytopathy. Alternatively, the concept of oligodendrocyte heterogeneity throughout the CNS is emerging (Hardy, Lazzarini, Colman, & Friedrich, 1996; Marques et al., 2016) and would equally support the hypothesis of a region-specific oligodendrocyte vulnerability toward osmotic insult.
In conclusion, we successfully generated a mouse model of ODS characterized by early and regional astrocytopathy and oligodendrocytopathy, resulting from the rapid correction of a chronic hyponatremia.
This gliopathy culminated with the activation of the necroptosis cascade and the loss of glial cells from the lesioned brain regions, prior to BBB disruption and demyelination. In addition, we showed that microglial cells are early activated in the course of ODS, possibly through direct or indirect signaling (i.e. osmotic stress, inflammatory stimuli, DAMPs) and that these cells could contribute to neuroinflammation.
This model will allow the use of genetically modified mice for exploring the function of specific genes in the pathophysiology of ODS.
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